TECH OUTLOOK 6OCTOBER - 2021TECH OUTLOOKEditorialStacey Smith Editor-in-Chiefeditor@pharmatechoutlook.comThe drug discovery industry witnessed growth in the past several years owing to progress in biochemical, translational and molecular studies in biomedical research. These technologies are commercially employed in the development of new and efficient drug candidates. The growing field of drug discovery and development enables researchers to focus on discovering essential lead compounds for different forms of cancer and other diseases. Biopharmaceutical companies and various research institutes are researching the field of drug discovery technologies. In addition, the COVID-19 pandemic has forced a rethink of how to manage clinical trials and treat patients in hospitals and their homes. And the breakneck speed of vaccine development in 2021 could potentially lead to accelerated timelines for other therapeutics in the future. With the spread of digitization across all industries, pharma companies must take advantage of the emerging technologies that will help them stay competitive in the market.In the past decades, advances in computing power, advances in robotics, biological techniques, and enhanced methodologies in synthetic chemistry have catapulted the drug discovery process to high-throughput screening for known disease-associated targets. Another disruptive technology, Artificial Intelligence (AI), especially deep learning and machine learning, is coming out as disruptive technology for the faster discovery and development of innovative therapies. The involvement of AI in developing a pharmaceutical product from the bench to the bedside can be imagined, given that it can aid rational drug design. Given the industry's reliance on text-based data in the form of clinical records, scientific papers, pharmaceutical companies' call centre transcriptions, Natural language processing (NLP) has the potential to streamline deciphering handwritten documents.As the space continues to evolve, it can be challenging for pharma companies to keep up with the changes and adapt. This edition of Pharma Tech Outlook brings you the companies providing cutting-edge drug discovery and development tech solutions/services. The edition also brings insightful articles from the industry experts. Let us know your thoughts.Ushering a New Age in Drug Development and DiscoveryCopyright © 2021 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.OCTOBER - 1 - 2021, Vol 07 - Issue 07 (ISSN 2644-2787) Published by ValleyMedia, Inc. To subscribe to Pharma Tech OutlookVisit www.pharmatechoutlook.com *Some of the Insights are based on the interviews with respective CIOs and CXOs to our editorial staffEditor-in-ChiefStacey SmithVisualizerRonald DonovanAsher BlakeEditorial StaffAaron Pierce Ava GarciaJenna VegasCarolynn Walters Justin SmithPaul BarberSalesBrian Thomasbrian@pharmatechoutlook.comPhone: 510.556.2402sales@pharmatechoutlook.comeditor@pharmatechoutlook.commarketing@pharmatechoutlook.comEmail:Contact Us:Phone:510.556.2402, Fax:510-894-8405TECH OUTLOOK
< Page 5 | Page 7 >